About
Technology
Issues
FAQ
Links
Official Page
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.